Spry keeps chronically ill patients in Loop
May 9, 2017
California start-up Spry Health has announced Loop, a combination of a clinical-grade wearable and disease management platform. Loop enhances timely care to chronically ill patients, with individualised analytics to improve patient outcomes, reduce hospitalisation and decrease spending by healthcare organisations.
Spry Health, incubated at the highly-selective Stanford-affiliated accelerator StartX, began in 2013 in the minds of founders Pierre-Jean Cobut and Elad Ferber while Stanford business school students.
Both founders have watched family members struggle with navigating the healthcare system with chronic illnesses: they came together with a mission to bring proactive care to chronically ill patients.
“The body is a system in constant change, but nobody is monitoring the micro-changes in patients with chronic conditions,” said Cobut, “We are building a solution to bridge gaps in traditional chronic care management.”
By design Spry Health developed Loop to be a catalyst for both better care and lower costs.
“In a given year, over 28 million hospitalisations are attributed to chronically ill patients, resulting in an average bill of $37,300 per stay with some patients winding up in the hospital three or more times per year,” said Ferber. “Empowering chronically ill patients is what drives the company’s dedicated team of experts in advanced health informatics, biological signals analysis and medical research.”
The Loop wearable continuously and noninvasively collects vital signs to assess the patient’s baseline and monitor how their condition evolves. Loop’s analytics platform pinpoints subtle physiological changes and delivers relevant, actionable insights to healthcare organisations before new symptoms are noticeable to the patient.
Healthcare organisations can then guide their most vulnerable members to the right care at the right time. The combination of an easy-to-use wearable with individualised analytics can increase peace of mind and compliance for patients, improve their outcomes, and prevent costly hospitalisations.
Spry Health conducted “one of the more comprehensive pre-market evaluations of a digital medical device ever published”, said Steve Steinhubl from Scripps Translational Science Institute.
The evaluation had more than 250 participants to prove the clinical equivalence of Loop against standards of care for blood pressure, heart rate, oxygen saturation, respiration and CO2 monitoring. Spry Health has submitted with the FDA and is seeking clearance for Loop by early 2018.